Two research groups have independently shown that targeting genes carrying passenger mutations blocked growth of cancer cells and improved survival in mice. Although precise therapeutic windows are undetermined, the researchers are planning to develop therapeutics that exploit the presence of those mutations to inhibit tumor growth.